copper intrauterine devices

Summary

Summary: Intrauterine contraceptive devices that depend on the release of metallic copper.

Top Publications

  1. ncbi [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)]
    F Imperato
    II Facolta di Medicina e Chirurgia, Istituto di Ostetricia e Ginecologia, Universita degli Studi La Sapienza, Rome, Italy
    Minerva Ginecol 54:271-8. 2002
  2. ncbi IUDs: which device?
    Jo Dennis
    Abacus Centres for Family Planning and Reproductive Health, Liverpool, UK
    J Fam Plann Reprod Health Care 28:61-8. 2002
  3. ncbi Mechanisms of action of intrauterine devices: update and estimation of postfertilization effects
    Joseph B Stanford
    Department of Family and Preventive Medicine, University of Utah Health Research Center, Salt Lake City 84108, USA
    Am J Obstet Gynecol 187:1699-708. 2002
  4. ncbi Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women
    D Hubacher
    Family Health International, Research Triangle Park, NC 27709, USA
    N Engl J Med 345:561-7. 2001
  5. ncbi Outcomes at 1 year for the first 200 patients fitted with GyneFix at Margaret Pyke Centre
    T Masters
    Avon Brook, Bristol, UK
    Eur J Contracept Reprod Health Care 7:65-70. 2002
  6. ncbi [Inconveniences and complications after insertion of IUDs by general practitioners]
    Jytte Rothmann Johansen
    København Universitet, Institut for Folkesundhedsvidenskab, Afdeling for Almen Medicin, København
    Ugeskr Laeger 166:3190-4. 2004
  7. ncbi The intrauterine device: rethinking old paradigms
    Katherine W Morgan
    University of Utah College of Nursing, 10 South 2000 East, Salt Lake City, UT 84112, USA
    J Midwifery Womens Health 51:464-70. 2006
  8. ncbi Attitudes of Israeli gynecologists towards the levonorgestrel-releasing intrauterine system: a questionnaire survey
    A Ben-Haroush
    Department of Obstetrics and Gynecology, Rabin Medical Center, Petach Tiqva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Eur J Contracept Reprod Health Care 9:29-33. 2004
  9. ncbi [Intrauterine devices in general practice: a prospective study of 300 insertions]
    H Marret
    Département de gynécologie obstétrique, Medecine Foetale et Reproduction Humaine, Hopital Bretonneau, 2, boulevard Tonnelle, 37044 Tours Cedex 1, France
    J Gynecol Obstet Biol Reprod (Paris) 31:465-70. 2002
  10. ncbi Intrauterine contraception: the role of general practitioners in four Dutch general practices
    Annika A G Vos
    Women s Studies in Medicine, Department of General Practice, University of Nijmegen, Nijmegen, The Netherlands
    Contraception 69:283-7. 2004

Research Grants

  1. Prophylactic Ibuprofen: Effect on IUD Continuation Rates
    David Hubacher; Fiscal Year: 2003
  2. PID IN IUD VS INJECTABLE CONTRACEPTIVE USERS PILOT STUDY
    Paul Feldblum; Fiscal Year: 2001
  3. ESTIMATING EFFICACY OF A MEDICAL INTERVENTION
    James Trussell; Fiscal Year: 2001
  4. RCT of a Novel Oral Contraceptive Initiation Method
    Carolyn Westhoff; Fiscal Year: 2004
  5. Clinical Research in Human Fertility
    Joseph Stanford; Fiscal Year: 2005
  6. Obesity, Oral Contraception and Ovarian Suppression
    Carolyn Westhoff; Fiscal Year: 2007

Detail Information

Publications161 found, 100 shown here

  1. ncbi [The role of copper-releasing intrauterine device or levonorgestrel-releasing intrauterine system on uterine bleeding and iron status (prospective study of 8 years)]
    F Imperato
    II Facolta di Medicina e Chirurgia, Istituto di Ostetricia e Ginecologia, Universita degli Studi La Sapienza, Rome, Italy
    Minerva Ginecol 54:271-8. 2002
    ..The authors evaluated the effect of copper surface area on uterine bleeding...
  2. ncbi IUDs: which device?
    Jo Dennis
    Abacus Centres for Family Planning and Reproductive Health, Liverpool, UK
    J Fam Plann Reprod Health Care 28:61-8. 2002
  3. ncbi Mechanisms of action of intrauterine devices: update and estimation of postfertilization effects
    Joseph B Stanford
    Department of Family and Preventive Medicine, University of Utah Health Research Center, Salt Lake City 84108, USA
    Am J Obstet Gynecol 187:1699-708. 2002
    ....
  4. ncbi Use of copper intrauterine devices and the risk of tubal infertility among nulligravid women
    D Hubacher
    Family Health International, Research Triangle Park, NC 27709, USA
    N Engl J Med 345:561-7. 2001
    ..The concern that IUDs that contain copper--currently the most commonly used type--may increase the risk of infertility in nulligravid women has limited the use of this highly effective method of birth control...
  5. ncbi Outcomes at 1 year for the first 200 patients fitted with GyneFix at Margaret Pyke Centre
    T Masters
    Avon Brook, Bristol, UK
    Eur J Contracept Reprod Health Care 7:65-70. 2002
    ..However, they are perhaps not as good as had been anticipated for this revolutionary new intrauterine implant. Possible reasons for this are explored...
  6. ncbi [Inconveniences and complications after insertion of IUDs by general practitioners]
    Jytte Rothmann Johansen
    København Universitet, Institut for Folkesundhedsvidenskab, Afdeling for Almen Medicin, København
    Ugeskr Laeger 166:3190-4. 2004
  7. ncbi The intrauterine device: rethinking old paradigms
    Katherine W Morgan
    University of Utah College of Nursing, 10 South 2000 East, Salt Lake City, UT 84112, USA
    J Midwifery Womens Health 51:464-70. 2006
    ..In light of this data, the IUD should be made available to women at low-risk for sexually-transmitted infections and should not be denied to women on the basis of parity or marital status...
  8. ncbi Attitudes of Israeli gynecologists towards the levonorgestrel-releasing intrauterine system: a questionnaire survey
    A Ben-Haroush
    Department of Obstetrics and Gynecology, Rabin Medical Center, Petach Tiqva and Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
    Eur J Contracept Reprod Health Care 9:29-33. 2004
    ..In addition, physician knowledge of patient satisfaction with the device was evaluated...
  9. ncbi [Intrauterine devices in general practice: a prospective study of 300 insertions]
    H Marret
    Département de gynécologie obstétrique, Medecine Foetale et Reproduction Humaine, Hopital Bretonneau, 2, boulevard Tonnelle, 37044 Tours Cedex 1, France
    J Gynecol Obstet Biol Reprod (Paris) 31:465-70. 2002
    To assess the effectiveness of management practices of copper intrauterine devices (IUD) in general medicine.
  10. ncbi Intrauterine contraception: the role of general practitioners in four Dutch general practices
    Annika A G Vos
    Women s Studies in Medicine, Department of General Practice, University of Nijmegen, Nijmegen, The Netherlands
    Contraception 69:283-7. 2004
    ..General practitioners clearly follow their own opinions about inserting IUD in nulliparous women. Currently, general practitioners are prescribing more Multiload Cu 375 IUDs and levonorgestrel-releasing IUDs...
  11. ncbi Clinical outcomes of early postplacental insertion of intrauterine contraceptive devices
    Sevki Celen
    Zekai Tahir Burak Women Health Education and Research Hospital, Ankara, Turkey
    Contraception 69:279-82. 2004
    ..To assess the efficacy, safety and, thus, advantages and disadvantages, of early postplacental intrauterine device (IUD) insertion...
  12. ncbi Problems in the conduct and analysis of "A comparative randomized study of three different IUDs in nulliparous Mexican women"
    Irving Sivin
    Contraception 69:259-60. 2004
  13. ncbi Ectopic pregnancy among non-medicated and copper-containing intrauterine device users: a 10-year follow-up
    Sanjay Ganacharya
    Department of Obstetrics and Gynecology, Medical and Health Science Center, University of Debrecen, P O Box 37, Nagyerdei krt 98, H 4012 Debrecen, Hungary
    Eur J Obstet Gynecol Reprod Biol 111:78-82. 2003
    ..To compare ectopic pregnancy (EP) rates among users of non-medicated and copper-containing IUDs...
  14. ncbi Insertion of intrauterine devices: a comparison of experience with Mirena and Multiload Cu 375 during post-marketing monitoring in New Zealand
    Mira Harrison-Woolrych
    Intensive Medicines Monitoring Programme, Department of Preventive and Social Medicine, University of Otago, Dunedin, New Zealand
    N Z Med J 116:U538. 2003
    ..To compare the incidence of reported insertion problems with the levonorgestrel-releasing intrauterine device (Mirena) with that of the copper device Multiload Cu 375...
  15. ncbi Randomized comparison of levonorgestrel- and copper-releasing intrauterine systems immediately after abortion, with 5 years' follow-up
    Paivi Pakarinen
    Steroid Research Laboratory, Biochemistry, Institute of Biomedicine, Biomedicum, University of Helsinki, Helsinki, Finland
    Contraception 68:31-4. 2003
    ..Mirena was more effective and the rate of adverse events was lower than with NovaT. Special attention should be paid to the insertion procedure when carried out at the time of abortion...
  16. ncbi [Effects of intrauterine contraceptive device on expression of vascular endothelial growth factor, kinase insert domain-containing receptor and microvessel density in endometrium]
    Zhi Min Xin
    Reproductive Medical Center, First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China
    Zhonghua Fu Chan Ke Za Zhi 39:771-5. 2004
    ....
  17. ncbi Effect of a levonorgestrel intrauterine system on women with type 1 diabetes: a randomized trial
    Svetlana Rogovskaya
    Research Center of Obstetrics, Gynecology, and Perinatology, Russian Academy of Medical Science, Moscow, Russia
    Obstet Gynecol 105:811-5. 2005
    ..To examine the effect of the levonorgestrel-releasing intrauterine system on glucose metabolism in diabetic women...
  18. ncbi The 'frameless' intrauterine system for long-term, reversible contraception: a review of 15 years of clinical experience
    Dirk Wildemeersch
    Contrel Research, Technology Park, University of Ghent, Belgium
    J Obstet Gynaecol Res 29:164-73. 2003
    ..The development of the 'frameless' intrauterine system (IUS) is a response to the growing need to develop high-performing, long-acting, reversible, and acceptable contraceptives with a high continuation of use...
  19. doi Intrauterine contraception: an update
    R K Bhathena
    Department of Obstetrics and Gynaecology, B D Petit Parsee General and Masina Hospitals, Bombay, India
    J Obstet Gynaecol 28:262-5. 2008
  20. ncbi Options for intrauterine contraception
    Heidi Collins Fantasia
    William F Connell School of Nursing, Boston College, Chestnut Hill, MA, USA
    J Obstet Gynecol Neonatal Nurs 37:375-83. 2008
    ..A greater understanding of the benefits and limitations of these two contraceptive options will assist women's health care providers to better meet the family planning needs of their patients...
  21. ncbi [Non hormonal contraception]
    Geoffroy Robin
    Service de gynécologie médicale et médecine du couple, Hopital Jeanne de Flandre, CHRU de Lille, 59037 Lille
    Rev Prat 58:29-40. 2008
    Excluded hormonal contraceptives, there are non hormonal means of contraception. Among them, copper intrauterine devices (IUD) are very efficient...
  22. ncbi IUD In Situ?
    Colleen Dy
    J Obstet Gynaecol Can 30:107-8. 2008
  23. ncbi Effect of different contraceptive methods on the oxidative stress status in women aged 40 48 years from the ELAN study in the province of Liege, Belgium
    J Pincemail
    Department of Cardiovascular Surgery, University of Liege, CHU Sart Tilman, 4000 Liege, Belgium
    Hum Reprod 22:2335-43. 2007
    ..Among conditions known to influence oxidative stress, the use of oral contraception (OC) in women has been a matter of ongoing discussion...
  24. ncbi New frameless and framed intrauterine devices and systems - an overview
    Dirk Wildemeersch
    Contrel Research, Technology Park, University of Ghent, 9000 Ghent, Belgium
    Contraception 75:S82-92. 2007
    ..In some women, the use of misoprostol 400 microg, 3 h prior to fitting of the IUD/IUS, may be useful to dilate the cervical canal. The popularity of the IUD could be much improved if attention is given to this aspect of IUD insertion...
  25. ncbi Cochrane systematic reviews of IUD trials: lessons learned
    David A Grimes
    Family Health, International, P O Box 13950, Research Triangle Park, NC 27796, USA
    Contraception 75:S55-9. 2007
    ..Intrauterine devices (IUDs) are the most widely used reversible contraceptives in the world today, and decisions about their use should reflect the best available evidence...
  26. ncbi A randomized trial on the clinical performance of Nova T380 and Gyne T380 Slimline copper IUDs
    Tommy Haugan
    Department of Epidemiology, SINTEF Health Research, N 7465 Trondheim, Norway
    Contraception 75:171-6. 2007
    The objective of this open randomized study was to compare the clinical performance of Nova T380 and Gyne T380 Slimline copper intrauterine devices (IUDs).
  27. ncbi Surgical management of intra-abdominal mislocated intrauterine devices
    Mahmut T Ozgun
    Department of Obstetrics and Gynecology, Faculty of Medicine, Gevher Nesibe Hospital, Erciyes University, 38039 Kayseri, Turkey
    Contraception 75:96-100. 2007
    ..We report on our experience in surgical treatment of patients with intra-abdominal intrauterine devices (IUDs)...
  28. ncbi Contraception for the older woman: an update
    R K Bhathena
    Department of Obstetrics and Gynaecology, Petit Parsee General and Masina Hospitals, Bombay, India
    Climacteric 9:264-76. 2006
    ..The woman should be provided with individualized advice so that she has a choice between the newer, effective, largely safe, reversible methods and sterilization...
  29. ncbi [Weight variation in users of the levonorgestrel-releasing intrauterine system, of the copper IUD and of medroxyprogesterone acetate in Brazil]
    Daniela Angerame Yela
    Departamento de Obstetricia e Ginecologia, Faculdade de Medicina, Universidade Estadual de Campinas UNICAMP, Campinas, Brazil
    Rev Assoc Med Bras 52:32-6. 2006
    ....
  30. ncbi Insertion of an intrauterine contraceptive device after induced or spontaneous abortion: a review of the evidence
    N L Stanwood
    Robert Wood Johnson Clinical Scholars Program, University of North Carolina School of Medicine, Chapel Hill, USA
    BJOG 108:1168-73. 2001
    ..Immediate insertion may have a higher expulsion rate than delayed insertion. However, these risks may be outweighed by the benefit of immediate contraception...
  31. ncbi TCu 380A IUD: a reversible permanent contraceptive method in women over 35 years of age
    Luis Bahamondes
    Human Reproduction Unit, Department of Obstetrics and Gynecology, School of Medicine, Universidade Estadual de Campinas UNICAMP, Campinas 13084 971, Brazil
    Contraception 72:337-41. 2005
    ..The objective of the study was to evaluate the performance of the TCu 380A IUD in women who had been using the device for more than 10 years and who were 35 years of age or more on completion of the 10th year of IUD use...
  32. ncbi Extending the time limit for starting the Yuzpe regimen of emergency contraception to 120 hours
    Charlotte Ellertson
    Ibis Reproductive Health, Cambridge, Massachusetts 02138, USA
    Obstet Gynecol 101:1168-71. 2003
    ..The purpose of this study was to determine whether the window for emergency hormonal contraception can be extended to 120 hours...
  33. ncbi State-of-the-art of non-hormonal methods of contraception: III. Intrauterine devices
    Irving Sivin
    Population Council, New York, NY10065, USA
    Eur J Contracept Reprod Health Care 15:96-112. 2010
    ..Yet other research lines indicate noncontraceptive benefits of copper intrauterine devices in protecting against endometrial cancer, and favourable risk-benefit analyses of IUD use by women at ..
  34. ncbi Efficacy of contraceptive methods: A review of the literature
    Diana Mansour
    New Croft Centre, Newcastle upon Tyne, UK
    Eur J Contracept Reprod Health Care 15:4-16. 2010
    ..To provide a comprehensive and objective summary of contraceptive failure rates for a variety of methods based on a systematic review of the literature...
  35. ncbi Copper hypersensitivity: dermatologic aspects--an overview
    Jurij J Hostynek
    Euromerican Technology Resources, Inc, Lafayette, California 94549, USA
    Rev Environ Health 18:153-83. 2003
    ..systemic allergic reactions (SAR) and contact stomatitis (STO), but considering the widespread use of copper intrauterine devices (IUDs) and the importance of copper in coinage, items of personal adornment and industry, unambiguous ..
  36. ncbi The 'tail' of a missing intrauterine contraceptive device
    Hanan Ismail
    Career Grade Trainee in Family Planning and Reproductive Health, Graingerville Clinic, Newcastle General Hospital, Newcastle upon Tyne, UK
    J Fam Plann Reprod Health Care 28:96-7. 2002
    ..Accurate ultrasound examination can ensure the avoidance of unnecessary x-rays or surgery. The case also acts as a reminder that a missing thread of an IUD does not imply that the device is misplaced...
  37. ncbi The local progestational effect of the levonorgestrel-releasing intrauterine system: a sonographic and Doppler flow study
    Y Zalel
    Department of Obstetrics and Gynecology, The Chaim Sheba Medical Center, affiliated to the Sackler Faculty of Medicine, Tel Aviv University, Tel Hashomer, Israel
    Hum Reprod 17:2878-80. 2002
    ..We aimed to evaluate the effect of the levonorgestrel-releasing intrauterine system (LNG-IUS) on the uterine vasculature and the endometrium...
  38. ncbi Efficacy of a mini version of the frameless GyneFix intrauterine system (IUS) with effective copper surface area of 200 mm2. dirk.wildemeersch@contrel.be
    Dirk Wildemeersch
    Contrel Research, Ghent, Belgium
    Contraception 66:237-41. 2002
    ..This is made possible by anchoring the active contraceptive substance to the fundus of the uterus. The fact that 100% of the copper surface area of the frameless IUS is available for copper release is an additional advantage...
  39. ncbi Intrauterine device use among women with ovarian cancer: a systematic review
    Lauren B Zapata
    Centers for Disease Control and Prevention, Atlanta, GA, 30341, USA
    Contraception 82:38-40. 2010
    ..Fertility-sparing treatment may be an option for women with early stage ovarian cancer and certain tumor types. This systematic review evaluated the evidence on the safety of intrauterine device (IUD) use by women with ovarian cancer...
  40. ncbi Alterations in copper homeostasis and oxidative stress biomarkers in women using the intrauterine device TCu380A
    Nathalie Arnal
    INIBIOLP Instituto de Investigaciones Bioquímicas de La Plata, CCT La Plata, CONICET UNLP, Catedra de Bioquimica y Biologia Molecular, Facultad de Ciencias Medicas, Universidad Nacional de La Plata, La Plata, Argentina
    Toxicol Lett 192:373-8. 2010
    ..We concluded that the use of Cu-IUDs for more than 2 consecutive years should be avoided in order to prevent oxidative damage...
  41. ncbi Removal of copper-bearing IUDs in asymptomatic patients. Reply
    Jyoti Jatti
    J Fam Plann Reprod Health Care 34:136. 2008
  42. ncbi Uterovesical fistula and bladder stones following bladder penetration by a perforating intrauterine contraceptive device
    A M E Nwofor
    Department of Surgery, Nnamdi Azikiwe University Teaching Hospital, Nnewi, Nigeria
    J Obstet Gynaecol 23:683-4. 2003
  43. ncbi Follow-up visits after IUD insertion. Are more better?
    D Hubacher
    Family Health International, Research Triangle Park, NC 27709, USA
    J Reprod Med 44:801-6. 1999
    ..To determine whether frequent follow-up visits for intrauterine device (IUD) users prevents the development of pelvic inflammatory disease (PID)...
  44. ncbi Does over-exposure to copper ions released from metallic copper induce cytotoxic and genotoxic effects on mammalian cells?
    Claudia A Grillo
    Instituto de Investigaciones Fisicoquimicas Teoricas y Aplicadas INIFTA, CCT CONICET La Plata, Facultad de Ciencias Exactas, Departamento de Quimica, Universidad Nacional de La Plata, La Plata, Argentina
    Contraception 81:343-9. 2010
    ..This work is focused on the assessment of the possible cyto- and genotoxic effects of different concentrations of copper ions released from metallic copper on mammalian cells in vitro...
  45. ncbi Erosion of an intrauterine contraceptive device through the bladder wall causing calculus: management and review of the literature
    Mahmoud Mustafa
    Urology Department, Osmaniye State Hospital, Osmaniye, Turkey
    Urol Int 82:370-1. 2009
    ..A 46-year-old women is described in whom intravesical migration of the intrauterine device was complicated by bladder stone formation. Endoscopic management was applied with an excellent outcome...
  46. ncbi Transuterine migration as a complication of intrauterine contraceptive devices: six case reports
    Y A Tuncay
    SSK Goztepe Educational Hospital, Clinic of Obstetrics and Gynecology, Istanbul, Turkey
    Eur J Contracept Reprod Health Care 9:194-200. 2004
    ..Although an IUD is an effective contraceptive method, the migration of one is a rare but serious complication. The aim of this report is to emphasize the management and therapy of this complication...
  47. ncbi Comparison of efficacy and complications of IUD insertion in immediate postplacental/early postpartum period with interval period: 1 year follow-up
    Kafiye Eroğlu
    Department of Obstetrics and Women s Health Nursing, School of Nursing, Hacettepe, University, 06100 Ankara, Turkey
    Contraception 74:376-81. 2006
    ..This study aimed to compare immediate postplacental (IPP) and early postpartum (EP) intrauterine device (IUD) insertions with interval (INT) IUD insertions with respect to efficacy and complications...
  48. ncbi Contraception and treatment in the perimenopause with a novel "frameless" intrauterine levonorgestrel-releasing drug delivery system: an extended pilot study
    D Wildemeersch
    Contrel Research, Technology Park Zwijnaarde, Ghent, Belgium
    Contraception 66:93-9. 2002
    ....
  49. ncbi Peritoneal abscess resulting from a translocated copper intrauterine device
    Jyoti Jatti
    Department of Gynaecology, Gloucestershire Royal Hospital, Gloucester, UK
    J Fam Plann Reprod Health Care 33:57-8. 2007
  50. ncbi Comparison of the release behaviors of cupric ions from metallic copper and a novel composite in simulated body fluid
    Juan Li
    State Key Laboratory of Mould Technology, College of Materials Science and Engineering, Huazhong University of Science and Technology, Wuhan 430074, People s Republic of China
    J Biomed Mater Res B Appl Biomater 85:172-9. 2008
    ..In view of the earlier results, this novel copper-containing composite might serve as a potential substitute for conventional materials of IUDs in the future...
  51. ncbi [Use of 3-dimensional ultrasound for assessment of intrauterine device position]
    I Hösli
    Geburtshilfe und Schwangerschaftsmedizin, Universitats Frauenklinik Basel
    Ultraschall Med 22:75-80. 2001
    ..The purpose of our prospective study was to assess the accuracy of measuring and visualizing different types of IUDs with three dimensional ultrasound (3D) and two dimensional ultrasound (2D)...
  52. pmc Emergency contraceptive options available for adolescents
    Vishal Gupta
    Pediatric Research in Emergency Therapeutics Program, Hospital for Sick Children, Toronto, Ontario, Canada
    Can Fam Physician 52:1219-20. 2006
    ..While many teenagers are unaware of these options, this armamentarium is very effective if used early after coitus and when further sexual activity is avoided for a few days...
  53. ncbi Local tissue effects of copper-containing intrauterine devices
    Kalman Patai
    Fertil Steril 80:1281-3. 2003
  54. ncbi Sonographic and Doppler flow characteristics of levonorgestrel and copper-releasing intrauterine devices
    Yaron Zalel
    Department of Obstetrics and Gynecology, Sheba Medical Center, Tel Hashomer, Israel
    MedGenMed 5:38. 2003
  55. ncbi Contraceptive use among solid organ transplant patients: a systematic review
    Melissa E Paulen
    Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 82:102-12. 2010
    ..Women undergoing solid organ transplantation are advised to avoid pregnancy for up to 24 months following transplant surgery...
  56. ncbi Asymptomatic ileal perforation of an intrauterine device
    S Disu
    Department of Obstetrics and Gynaecology, Elizabeth Garrett Anderson Hospital, University College London Hospitals NHS Trust, Huntley Street, London, WC1E 6DH, UK
    Arch Gynecol Obstet 269:230-1. 2004
    ..The apparent insertion of the IUD was asymptomatic and she remained asymptomatic for a period of 8 years prior to presentation...
  57. ncbi Hemoglobin measurement prior to initiating copper intrauterine devices: a systematic review
    Naomi K Tepper
    Division of Reproductive Health, Centers for Disease Control and Prevention, Atlanta, GA 30341, USA
    Contraception 87:639-44. 2013
    Women using copper intrauterine devices (IUDs) frequently experience bleeding abnormalities. This review was conducted to evaluate the evidence regarding whether hemoglobin levels should be measured prior to copper IUD insertion.
  58. ncbi [Summary of the practice guideline 'The intrauterine device' from the Dutch College of General Practitioners]
    Froukje S Boukes
    Nederlands Huisartsen Genootschap, afd Richtlijnontwikkeling en Wetenschap, Utrecht, The Netherlands
    Ned Tijdschr Geneeskd 153:A578. 2009
    ..Therefore prior to insertion, the general practitioner should enquire about the risk of a SOA being present and, if necessary, perform SOA tests. In the Netherlands, IUD insertion can usually be performed at a general practice...
  59. ncbi Blood copper levels in Mexican users of the T380A IUD
    Dolores De la Cruz
    Unidad Universitaria de Investigación en Cariología University Cariology Research Unit, FES Zaragoza, Universidad Nacional Autonoma de Mexico, Mexico City, Mexico
    Contraception 72:122-5. 2005
    ..However, there are few reports of its systemic health effects. This study evaluates the association between the use of T380A IUD and blood Cu levels in a group of Mexican users...
  60. ncbi Association of age and parity with intrauterine device expulsion
    Tessa Madden
    Division of Clinical Research, Department of Obstetrics and Gynecology, Washington University in St Louis School of Medicine, St Louis, Missouri
    Obstet Gynecol 124:718-26. 2014
    To investigate whether age 14 to 19 years and nulliparity are associated with expulsion of levonorgestrel and copper intrauterine devices (IUDs).
  61. ncbi Evaluation of endometrial steroid receptors and cell mitotic activity in women using copper intrauterine device: Can Cu-T prevent endometrial cancer?
    Kiran Guleria
    Department of Obstetrics and Gynecology, University College of Medical Sciences and GTB Hospital, Delhi, India
    J Obstet Gynaecol Res 30:181-7. 2004
    ..e. cell mitosis and Ki67), endometrial steroid (estrogen and progesterone) receptors, and serum estradiol and progesterone level in women using copper intrauterine device (IUD) after 6 months of use...
  62. ncbi Development of a liquid chromatography-tandem mass spectrometry method for measuring plasma and uterine tissue levels of indomethacin in rabbits treated with indomethacin-medicated Cu-IUDs
    Youping Liu
    Laboratory of Drug Metabolism and Pharmacokinetics, Shenyang Pharmaceutical University, Shenyang 110016, PR China
    Contraception 85:419-24. 2012
    Some side effects of copper intrauterine devices (Cu-IUDs) including increased uterine bleeding, pelvic infections and pain have been reported...
  63. ncbi Levonorgestrel-releasing and copper intrauterine devices and the risk of breast cancer
    Jürgen Dinger
    ZEG Berlin Center for Epidemiology and Health Research, Germany
    Contraception 83:211-7. 2011
    ..This study compares the risk of breast cancer for levonorgestrel-releasing intrauterine devices (LNG(IUD)) versus copper IUDs (CU(IUD)) in women younger than 50 years of age...
  64. ncbi Safety of intrauterine contraceptive device (copper T 200 B) in women with cardiac disease
    Vanita Suri
    Department of Obstetrics and Gynecology, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India
    Contraception 78:315-8. 2008
    ..Women with cardiac disease are at increased risk for bacterial endocarditis. There is limited research regarding the use of intrauterine contraceptive devices (IUD) in women with cardiac disease...
  65. ncbi Effects of a progestogen-only pill (Exluton) and an intrauterine device (Multiload Cu250) on breastfeeding
    W Sinchai
    Regional Health Promotion Center, Khon Khaen, Thailand
    Adv Contracept 11:143-55. 1995
    ..This study confirms that both Exluton and Multiload Cu250 are acceptable and safe contraceptive methods in breastfeeding women...
  66. ncbi Copper intrauterine devices in the management of secondary amenorrhea
    N Dubey
    Lady Hardinge Medical College and Smt Sucheta Kriplani Hospital, New Delhi, India
    Int J Gynaecol Obstet 95:159-60. 2006
  67. ncbi [Penetrated IUD as the cause of stricture in the sigmoid colon]
    Louise Schouborg Brinth
    Hvidovre Hospital, Gastroenheden, Kirurgisk Sektion
    Ugeskr Laeger 169:143-4. 2007
    ..Laparotomy showed that the IUD had perforated the uterus and penetrated the sigmoid colon. Resection was performed. This case demonstrates the need to investigate every case of a missing IUD...
  68. ncbi Intrauterine devices and adolescents
    Melanie A Gold
    Division of Adolescent Medicine, Department of Pediatrics, University of Pittsburgh School of Medicine, PA 15213, USA
    Curr Opin Obstet Gynecol 20:464-9. 2008
    ..The purpose of this review is to inform the reader of new information published on intrauterine devices (IUDs) and adolescents...
  69. ncbi What is it about intrauterine devices that women find unacceptable? Factors that make women non-users: a qualitative study
    Claire Asker
    All Saints Medical Centre, Kings Heath, Birmingham, UK
    J Fam Plann Reprod Health Care 32:89-94. 2006
    ..This study explores how women's lay beliefs and perceptions about IUDs lead to rejection of this contraceptive choice...
  70. ncbi Copper T380A intrauterine device: lost and found
    Bliss Kaneshiro
    Department of Obstetrics and Gynecology, University of Hawai i, Honolulu, HI 96826, USA
    Hawaii Med J 67:131-2. 2008
  71. ncbi Contraceptive efficacy of an intra-uterine device in Brahman cattle
    G Fordyce
    Department of Primary Industries, Queensland Beef Industry Institute, P O Box 976, Qld 4820, Charters Towers, Australia
    Anim Reprod Sci 65:193-204. 2001
    ....
  72. ncbi Tubal pathology: the role of hormonal contraception, intrauterine device use and Chlamydia trachomatis infection
    Gabriele S Merki-Feld
    Department of Gynecology and Obstetrics, Endocrinology Clinic, University Hospital Zurich, Zurich, Switzerland
    Gynecol Obstet Invest 63:114-20. 2007
    The aim of the present study was to identify a possible association between tubal pathology and the contraceptive methods previously used, especially third generation copper intrauterine devices (IUDs).
  73. ncbi [Modern intra-uterine contraception: a better option]
    J V Hamerlynck
    Academisch Medisch Centrum, afd Verloskunde en Gynaecologie, Postbus 22 700, 1100 DE Amsterdam
    Ned Tijdschr Geneeskd 145:1621-4. 2001
    ....
  74. ncbi Insertion and removal of intrauterine devices
    Brett Andrew Johnson
    Methodist Charlton Medical Center, Dallas, Texas 75237, USA
    Am Fam Physician 71:95-102. 2005
    ..The IUD is inserted into the uterus according to individual protocols, with the threads cut at a length to allow the patient to check the device's position. Expulsion may occur with both types of IUDs...
  75. ncbi [Reasons for removal of intrauterine devices among women in general practice]
    Line Kolding
    Kvindeafdelingen, Regionshospitalet Viborg, Heibergs Alle 4, 8800 Viborg, Denmark
    Ugeskr Laeger 175:884-6. 2013
    ..In general the women were satisfied with both types of IUDs. More women with copper-releasing IUDs had an early removal because of complaints than women with levonorgestrel-releasing IUDs...
  76. ncbi Pain from copper intrauterine device insertion: randomized trial of prophylactic ibuprofen
    David Hubacher
    Family Health International, Research Triangle Park, NC, USA
    Am J Obstet Gynecol 195:1272-7. 2006
    ..This study was undertaken to determine whether 400 mg of prophylactic ibuprofen can alleviate pain from insertion of an intrauterine device (IUD) and to measure level of pain with improved techniques...
  77. ncbi Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action
    María Elena Ortiz
    Instituto Chileno de Medicina Reproductiva, Postal code 6500970, Santiago, Chile
    Contraception 75:S16-30. 2007
    ..The common belief that the usual mechanism of action of IUDs in women is destruction of embryos in the uterus is not supported by empirical evidence...
  78. ncbi Combined oral contraceptive and intrauterine device use among women with gestational trophoblastic disease
    Mary E Gaffield
    Department of Reproductive Health and Research, World Health Organization, 1211 Geneva 27, Switzerland
    Contraception 80:363-71. 2009
    ..Women diagnosed with gestational trophoblastic disease (GTD) need safe and effective contraception because they are advised to delay a subsequent pregnancy...
  79. ncbi Copper T 380A IUD and magnetic resonance imaging
    Miriam Zieman
    Department of Gynecology and Obstetrics, Emory University School of Medicine, Atlanta, GA 30303, USA
    Contraception 75:93-5. 2007
    ..Prior testing of the Copper T 380A intrauterine device (IUD) has been done using MR systems of 1.5 T or less. This study was performed to test this IUD in a MR system of 3.0 T...
  80. ncbi Reaching providers is not enough to increase IUD use: a factorial experiment of 'academic detailing' in Kenya
    Jennifer Wesson
    Family Health International, North Carolina, USA
    J Biosoc Sci 40:69-82. 2008
    ..However, the cost of the detailing in comparison to the small number of IUDs inserted indicates that this intervention is not cost-effective...
  81. ncbi Copper intrauterine device use by nulliparous women: review of side effects
    David Hubacher
    Family Health International, PO Box 13950, Research Triangle Park, NC 27709, USA
    Contraception 75:S8-11. 2007
    ..Nulliparity was once a relative contraindication to using the copper IUD. However, new research and changes in product labeling have eased safety concerns. Side effects remain a major problem with copper IUD use in this population...
  82. ncbi The acceptance rate of intrauterine contraceptive device (IUCD) amongst family planning clinic users in Lagos University Teaching Hospital (LUTH)
    O Adegbola
    Department of Obstetrics and Gynaecology, College of Medicine, University of Lagos, Lagos University Teaching Hospital, Lagos
    Nig Q J Hosp Med 18:175-80. 2008
    ..Intrauterine Contraceptive Device is an effective reversible long-term contraceptive method that is popular and widely used in this environment...
  83. ncbi Do users of the intrauterine system (Mirena) have different genital symptoms and vaginal flora than users of the intrauterine contraceptive device?
    R Neale
    Department of Genitourinary Medicine, Royal Cornwall Hospital NHS Trust, Truro, Cornwall TR1 3LJ, UK
    Int J STD AIDS 20:423-4. 2009
    ..More women with an IUCD developed BV compared with an IUS at 4-6 weeks and six months. However, there were insufficient numbers of women with BV to demonstrate any significant difference between the vaginal flora of the two groups...
  84. ncbi Effects of Mirena (levonorgestrel-releasing intrauterine system) and Ortho Gynae T380 intrauterine copper device on lipid metabolism--a randomized comparative study
    Ying Woo Ng
    Department of Obstetrics and Gynaecology, National University Hospital, Singapore 119074, Singapore
    Contraception 79:24-8. 2009
    ..This study aims to assess the effects of levonorgestrel-releasing intrauterine system (LNG-IUS) on lipid metabolism in an Asian population using Ortho Gynae T380 copper containing (nonhormonal) intrauterine device (IUD) as a control...
  85. pmc Contraception and HIV infection in women
    Oskari Heikinheimo
    Department of Obstetrics and Gynaecology, University of Helsinki, Finland
    Hum Reprod Update 15:165-76. 2009
    ..This review aims to show the effect of contraceptive choices on risk of HIV and on the course of disease in women with HIV...
  86. ncbi Pyosalpinx caused by the tubal migration of an intrauterine device--a case report
    Suna Ozdemir
    Department of Gynaecology and Obstetrics, Meram Medical Faculty, Selcuk University, Konya, Turkey
    Eur J Contracept Reprod Health Care 13:320-2. 2008
    ..Tubal migration of an IUD is extremely rare and little is known about its mechanism. We describe a case of pyosalpinx caused by the tubal migration of a copper IUD. The tail of the device was embedded in the mesocolon...
  87. ncbi Effects of a copper-medicated intrauterine device on ovarian artery, uterine artery, and intrauterine blood flow
    O Shen
    Department of Obstetrics and Gynecology, Shaare Zedek Medical Center, Jerusalem, Israel
    Gynecol Obstet Invest 66:253-6. 2008
    ..To determine the effect of a copper-medicated intrauterine device (IUD) on ovarian, uterine, arcuate, radial and subendometrial Doppler-derived indices of blood flow...
  88. ncbi Estrogen-progestogen once-a-month injectable contraceptives and serum prolactin
    J Garza-Flores
    Departamento de Biologia, Instituto Nacional de la Nutrición S Zubirán, Mexico City, Mexico
    Contraception 39:519-29. 1989
    ..Overall, the data demonstrated that the chronic administration of these estrogen/progestogen once-a-month injectable contraceptives does not affect the Prl baseline secretion in women...
  89. ncbi Unrecognised perforation of the uterus into bladder by an IUD
    A Honarbakhsh
    Department of Radiology and Ultrasonography, Madaen Hospital, Tehran, Iran
    J Obstet Gynaecol 23:444-5. 2003
  90. ncbi Can intrauterine contraceptive devices be a Candida albicans reservoir?
    Francieli Chassot
    Division of Clinical Cytology, Teaching and Research in Clinical Analysis Laboratory, State University of Maringa, Maringa, Parana, Brazil
    Contraception 77:355-9. 2008
    ..The in vitro adherence of Candida albicans isolated from vaginal exudates of patients with vulvovaginal candidiasis (VVC) to intrauterine contraceptive devices (IUDs) and biofilm formation capacity were evaluated...
  91. ncbi The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline
    I Mavranezouli
    National Collaborating Centre for Women s and Children s Health NCC WCH, Royal College of Obstetricians and Gynaecologists, London, UK
    Hum Reprod 23:1338-45. 2008
    ..However, their uptake is low in much of the developed world. This study aimed at assessing the cost-effectiveness of LARC methods from the British National Health Service (NHS) perspective...
  92. ncbi Release behavior of cupric ions for TCu380A and TCu220C IUDs
    Bianmei Cao
    School of Materials Science and Engineering, University of Science and Technology Beijing, Beijing, People s Republic of China
    Biomed Mater 3:044114. 2008
    ..The main compounds identified were cuprite (Cu(2)O). Copper wire and copper tubes were implanted in the uteruses of rats. In vivo experiments were also done. The corrosion rate in vivo was higher than that in vitro...
  93. ncbi Late uterine perforation with an anchored IUD, the Gynefix: a case report
    M Vekemans
    Universite Libre de Bruxelles, Brussels, Belgium
    Contraception 60:55-6. 1999
    ..The incidence of this complication is unknown. The appropriateness or need of assessing echo-graphically the myometrial thickness before the insertion and of controlling its correct position after the insertion remains uncertain...
  94. ncbi Persistent subumbilical discharge associated with actinomycosis caused by intrauterine contraceptive device: a case report
    Ibrahim Polat
    Gynecological Clinic, Istanbul Bakirkoy Woman and Children Hospital, Istanbul, Turkey
    Arch Gynecol Obstet 277:457-60. 2008
    ..We recommend consideration of this minor possibility during evaluation of women with chronic abdominal discharge...
  95. ncbi Transverse limb reduction and intrauterine device: case report and review of the literature
    Alina Weissmann-Brenner
    Helen Schneider Hospital for Women, Rabin Medical Center, Campus Beilinson, Petah Tiqva, Israel
    Eur J Contracept Reprod Health Care 12:294-7. 2007
    ..Pregnancies with an intrauterine device (IUD) in situ are associated with increased maternal and foetal morbidity and mortality. No proven teratogenetic effects have been attributed to IUDs...
  96. ncbi Magnetic resonance imaging appearances of the Mirena and GyneFix intra-uterine contraceptive devices: a report of two cases
    G H Hall
    Centre for Magnetic Resonance Investigations, University of Hull at Hull Royal Infirmary, Hull, UK
    Br J Fam Plann 26:224-6. 2000
    ....
  97. ncbi Depot medroxyprogesterone acetate and basal serum prolactin levels in lactating women
    S Ratchanon
    Reproductive Medicine and Family Planning Units, Department of Obstetrics and Gynecology, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand
    Obstet Gynecol 96:926-8. 2000
    ..To study the effect of depot medroxyprogesterone acetate on basal serum prolactin levels in lactating women...
  98. ncbi Intrauterine device insertion during the postpartum period: a systematic review
    Nathalie Kapp
    Department of Reproductive Health and Research, World Health Organization, CH 1211 Geneva 27, Switzerland
    Contraception 80:327-36. 2009
    ..Insertion of an intrauterine device (IUD) at different times or by different routes during the postpartum period may increase the risk of complications...
  99. ncbi The intrauterine device in modern contraception: Still an actuality?
    Andrea Tinelli
    Department of Obstetrics and Gynecology, Vito Fazzi Hospital, Lecce, Italy
    Eur J Contracept Reprod Health Care 11:197-201. 2006
    ....
  100. ncbi Uterine factors and risk of pregnancy in IUD users: a nested case-control study
    Angels Avecilla-Palau
    Centre d Atenció a la Salut Sexual i Reproductiva, Hospital Municipal de Badalona, Badalona Serveis Assistencials, C Mare de Déu de Lorda 119 125, 08915 Badalona, Spain
    Contraception 67:235-9. 2003
    ..The findings suggest that the gynecological characteristics of the woman analyzed should not be a criterion for the selection of potential IUD users...
  101. ncbi Intrauterine contraceptive devices and risk of pelvic inflammatory disease: standard of care in high STI prevalence settings
    Richard Steen
    Reprod Health Matters 12:136-43. 2004
    ..Even with safe insertion, IUD promotion in areas of high STI/HIV prevalence must address women's needs for dual protection from infection and unwanted pregnancy...

Research Grants6

  1. Prophylactic Ibuprofen: Effect on IUD Continuation Rates
    David Hubacher; Fiscal Year: 2003
    ..In the US, ibuprofen may help spur renewed interest in the most cost effective and efficacious reversible contraceptive method available. ..
  2. PID IN IUD VS INJECTABLE CONTRACEPTIVE USERS PILOT STUDY
    Paul Feldblum; Fiscal Year: 2001
    ..a randomized controlled trial comparing the incidence of pelvic inflammatory disease (PID) in users of copper intrauterine devices (IUDs) to the incidence in users of injectable depotmedroxyprogesterone acetate (DMPA)...
  3. ESTIMATING EFFICACY OF A MEDICAL INTERVENTION
    James Trussell; Fiscal Year: 2001
    ....
  4. RCT of a Novel Oral Contraceptive Initiation Method
    Carolyn Westhoff; Fiscal Year: 2004
    ..We will also assess dual method use for STD prevention in the study to adoption of and adherence to oral contraceptives. We will also assess dual method use for STD prevention in the study population. ..
  5. Clinical Research in Human Fertility
    Joseph Stanford; Fiscal Year: 2005
    ..Standford to develop his skills and gain the expertise needed to accomplish his goals. ..
  6. Obesity, Oral Contraception and Ovarian Suppression
    Carolyn Westhoff; Fiscal Year: 2007
    ..This study will have very good power to detect clinically important differences. Results could directly and immediately affect contraceptive practice. ..